Don Healey

Chief Technology Officer • Adicet Bio

Dr. Healey joined Adicet in October 2020 as Chief Technology Officer with nearly two decades of experience in cell therapy development and manufacturing. He joins Adicet most recently from KBI Biopharma Inc., a biopharmaceutical contract services organization, where he was responsible for establishing process development, manufacturing, quality control and facilities management for biopharmaceutical clients developing cellular therapies. Previously, he served as Chief Scientific Officer at Opexa Therapeutics, Inc., where he was responsible for all pre-clinical scientific development, closed-system process design and the scaling of Opexa’s autologous T-cell immunotherapy. Dr. Healey has also served as Director of Immunology at Argos Therapeutics Inc. and Group leader for Immunology at ML Laboratories, UK, (formerly Cobra Biotherapeutics). Dr. Healey received his Ph.D. from University of London, and holds a B.Sc. in Cellular Pathology from Bristol University.

Also Speaking

Justin Skoble

Vice President, Head of Technical Operations • Caribou Biosciences

Ricardo Baptista

Chief Technology Officer • Alder Therapeutics

Adam Mcleod

Senior Scientist • Cytiva

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.